Suchergebnisse - "Asselah, Tarik"

PubPharm (26)

1

What is the Path Forward to Treat Hepatitis Delta Virus? : Old Treatments and New Options

enthalten in: Clinics in liver disease | 2023

von Asselah, T.

2

Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1) : a multicentre, double-blind, active-controlled, randomised, phase 2b trial

enthalten in: The lancet. Gastroenterology & hepatology | 2023

von Yuen, M. | Asselah, T. | Jacobson, I. | +116

CommentIn: Lancet Gastroenterol Hepatol. 2023 Sep;8(9):772-773. - PMID 37442151

3

Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries

enthalten in: Journal of hepatology | 2023

von Razavi, H. | Buti, M. | Terrault, N. | +89

4

Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection

enthalten in: Gut | 2023

von Janssen, H. | Hou, J. | Asselah, T. | +16

5

Hepatitis D Virus Infection

enthalten in: The New England journal of medicine | 2023

von Asselah, T. | Rizzetto, M.

CommentIn: N Engl J Med. 2023 Oct 12;389(15):1441. - PMID 37819968

6

Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection

enthalten in: The New England journal of medicine | 2022

von Yuen, M. | Lim, S. | Plesniak, R. | +132

CommentIn: N Engl J Med. 2022 Nov 24;387(21):1996-1998. - PMID 36346068

7

Non-invasive diagnosis and follow-up of chronic infection with hepatitis B virus

enthalten in: Clinics and research in hepatology and gastroenterology | 2022

von Leroy, V. | Chevaliez, S. | Decraecker, M. | +10

8

Editorial : HBV cure-the quest for biomarkers to predict off-treatment sustained response

enthalten in: Alimentary pharmacology & therapeutics | 2021

von Thibault, V. | Asselah, T.

CommentOn: Aliment Pharmacol Ther. 2021 Jan;53(2):314-320. - PMID 33222190

9

Hepatitis B surface antigen seroclearance : Immune mechanisms, clinical impact, importance for drug development

enthalten in: Journal of hepatology | 2020

von Tout, I. | Loureiro, D. | Mansouri, A. | +3

10

A same day 'test and treat' model for chronic HCV and HBV infection : Results from two community-based pilot studies in Egypt

enthalten in: Journal of viral hepatitis | 2020

von Shiha, G. | Soliman, R. | Serwah, A. | +3